Semax is a synthetic nootropic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) derived from the ACTH(4-7) fragment, developed in Russia. It is studied for its effects on cognition, increased BDNF, focus, memory, and neuroprotection.
Composition
5 mg per vial
Experimental Exposure (Research)
Research exposure: 200–600 mcg
Adjust according to experimental protocol
For laboratory use only
Informational Benefits (Research)
Cognitive enhancement studies
Research on concentration and attention
Potential mental well-being support
Exploration of neuroprotective effects
Stress resistance studies
Brain function analysis
For research use only - Not for human consumption.
